Format

Send to

Choose Destination
Clin Genitourin Cancer. 2013 Sep;11(3):370-3. doi: 10.1016/j.clgc.2013.04.005. Epub 2013 May 9.

Curability of poor-risk metastatic sarcomatoid renal cell carcinoma with the combination of gemcitabine, 5-fluorouracil, and interferon-alfa: a case report of a 55-year-old man with a 10-year complete remission.

Author information

1
Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. hjconter@mdanderson.org

KEYWORDS:

5-Fluorouracil; Biochemotherapy; Gemcitabine; Interferon-alfa; Metastatic Carcinoma; Sarcomatoid Renal Cell carcinoma

PMID:
23665133
DOI:
10.1016/j.clgc.2013.04.005
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center